Investors Warned of Class Action Regarding iTonic Holdings Securities Losses
On September 10, 2026, a critical shareholder alert has been issued concerning iTonic Holdings Ltd, previously known as Pheton Holdings Ltd. This alert comes in light of a pending securities class action lawsuit that accuses the company and its associates of failing to disclose material risks pertaining to potential manipulation. If you invested in iTonic during the class period from September 5, 2024, through July 29, 2025, you may be entitled to recover your losses.
The lawsuit points to a dramatic incident on July 29, 2025, where shares of iTonic plunged approximately 95% in just one trading session. This drastic decline was preceded by multiple NASDAQ trading halts related to volatility. The company undertook an offering at a price of $4.00 per share, raising $9 million gross, which investors now wish to reevaluate in light of new allegations. The court has set a deadline of September 29, 2026, for investors to apply for lead plaintiff status.
Joseph E. Levi, Esq., a legal representative for affected shareholders, emphasized that transparency is paramount and that investors deserve to be informed about risks that could impact their investments. He stated, “This action examines whether those who facilitated iTonic's public offering adequately disclosed risks of manipulation they allegedly observed in other international microcap listings.”
The lawsuit outlines several alarming issues related to the underwriting and auditing process of iTonic’s IPO. It alleges that the underwriters, alongside the company's auditor, participated in a series of questionable foreign microcap listings that resulted in extreme price fluctuations, making them aware of the associated risks during iTonic's IPO process.
Investors have expressed concern regarding patterns of manipulation seen in previous microcap listings, which reportedly reflect a similar trajectory to iTonic’s decline. These include a concerning concentration of voting power held offshore and the issuance of vague risk disclosures that fail to provide specific details on the manipulation risks.
In addition, the lawsuit highlights two major weaknesses in the internal controls regarding financial reporting within iTonic’s subsidiary, paired with a reported revenue of $628,591 for 2023, which is minuscule compared to its peak share price of $32.00.
A noteworthy mention is a congressional committee letter that identified iTonic as potentially being associated with stock manipulation. On August 1, 2025, the company stated that its share price was influenced by false rumors, particularly concerning alleged dealings with Gilead Sciences, which it later denied. This revelation raises serious questions for investors who bought shares at inflated prices.
For those who might qualify as eligible participants in this class action, it is advisable to gather documentation evidencing purchase dates, share quantities, and investment amounts. Whether or not you still hold your shares, the eligibility focuses on when they were purchased and at which price.
Potential investors should take immediate action to gather their brokerage records and contact SueWallSt for no-cost evaluations on their eligibility to join the lawsuit. The class action is led by experienced attorneys from Levi & Korsinsky LLP, known for their robust track record in recovering significant settlements for shareholders.
Overall, the class action against iTonic Holdings seeks to address the grave concerns raised by investors regarding disclosure transparency and alleged market manipulation that resulted in substantial financial damage. To learn more about your rights as an investor and join the action, reach out to SueWallSt now.
For further inquiries or assistance, please contact Joseph E. Levi at [email protected] or call (888) SueWallSt. Remember, taking prompt action may aid in recovering potential losses you have suffered due to these alarming developments with iTonic Holdings.
The lawsuit points to a dramatic incident on July 29, 2025, where shares of iTonic plunged approximately 95% in just one trading session. This drastic decline was preceded by multiple NASDAQ trading halts related to volatility. The company undertook an offering at a price of $4.00 per share, raising $9 million gross, which investors now wish to reevaluate in light of new allegations. The court has set a deadline of September 29, 2026, for investors to apply for lead plaintiff status.
Joseph E. Levi, Esq., a legal representative for affected shareholders, emphasized that transparency is paramount and that investors deserve to be informed about risks that could impact their investments. He stated, “This action examines whether those who facilitated iTonic's public offering adequately disclosed risks of manipulation they allegedly observed in other international microcap listings.”
The lawsuit outlines several alarming issues related to the underwriting and auditing process of iTonic’s IPO. It alleges that the underwriters, alongside the company's auditor, participated in a series of questionable foreign microcap listings that resulted in extreme price fluctuations, making them aware of the associated risks during iTonic's IPO process.
Investors have expressed concern regarding patterns of manipulation seen in previous microcap listings, which reportedly reflect a similar trajectory to iTonic’s decline. These include a concerning concentration of voting power held offshore and the issuance of vague risk disclosures that fail to provide specific details on the manipulation risks.
In addition, the lawsuit highlights two major weaknesses in the internal controls regarding financial reporting within iTonic’s subsidiary, paired with a reported revenue of $628,591 for 2023, which is minuscule compared to its peak share price of $32.00.
A noteworthy mention is a congressional committee letter that identified iTonic as potentially being associated with stock manipulation. On August 1, 2025, the company stated that its share price was influenced by false rumors, particularly concerning alleged dealings with Gilead Sciences, which it later denied. This revelation raises serious questions for investors who bought shares at inflated prices.
For those who might qualify as eligible participants in this class action, it is advisable to gather documentation evidencing purchase dates, share quantities, and investment amounts. Whether or not you still hold your shares, the eligibility focuses on when they were purchased and at which price.
Potential investors should take immediate action to gather their brokerage records and contact SueWallSt for no-cost evaluations on their eligibility to join the lawsuit. The class action is led by experienced attorneys from Levi & Korsinsky LLP, known for their robust track record in recovering significant settlements for shareholders.
Overall, the class action against iTonic Holdings seeks to address the grave concerns raised by investors regarding disclosure transparency and alleged market manipulation that resulted in substantial financial damage. To learn more about your rights as an investor and join the action, reach out to SueWallSt now.
For further inquiries or assistance, please contact Joseph E. Levi at [email protected] or call (888) SueWallSt. Remember, taking prompt action may aid in recovering potential losses you have suffered due to these alarming developments with iTonic Holdings.
Topics Financial Services & Investing）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.